A GSK-3 inhibitor
Catalog #: 1673 | abID:

Product Details

Cat # +Size 1673-1
Size 1 mg
Alternate Name (2Z, 3E)-6’-Bromo-3-(hydroxyimino)-[2,3’-biindolinylidene]-2’-one
Appearance Crystalline solid
CAS # 667463-62-9
Molecular Formula C₁₆H₁₀BrN₃O₂
Molecular Weight 356.17
Purity ≥98%
Solubility DMSO (10 mg/ml) or EtOH (0.5 mg/ml)
InChi InChI=1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,20,22H,(H,19,21)/b15-13-
PubChem CID 5287844
MDL Number MFCD08705318
Handling Protect from air and light
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


A potent, selective, reversible and ATP-competitive inhibitor of GSK-3α/β (IC₅₀ = 5 nM). Under a feeder-free condition, BIO maintains embryonic stem cells (hESCs) in the undifferentiated state.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Huhehasi Wu, Phosphorylation Regulates CAP1 (Cyclase-Associated Protein 1) Functions in the Motility and Invasion of Pancreatic Cancer Cells. Sci Rep, Mar 2019;   30894654.
Zhou et al., Phosphorylation of the cytoskeletal protein CAP1 controls its association with cofilin and actin. J. Cell Sci., Dec 2014; 127: 5052 - 5065.
For more citations of this product click here